Retraction Note: Hybrid nanoparticulate system of Fluvastatin loaded phospholipid, alpha lipoic acid and melittin for the management of colon cancer

Sci Rep. 2024 Nov 13;14(1):27831. doi: 10.1038/s41598-024-78897-z.

Mohamed A Alfaleh^{1

2}, Omar Fahmy³, Mohammed W Al-Rabia⁴, Mohammed A S Abourehab^{5

6}, Osama A A Ahmed¹, Usama A Fahmy⁷, Helal H Alsulimani¹, Shaimaa M Badr-Eldin^{1

8}, Hibah M Aldawsari^{1

9}, Bander M Aldhabi¹, Awaad S Alharbi¹, Nabil A Alhakamy^{1

9

10}

¹ Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
² Vaccines and Immunotherapy Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
³ Department of Urology, Universiti Putra Malaysia, 43400, Selangor, Malaysia.
⁴ Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
⁵ Department of Pharmaceutics, and Industrial Pharmacy, Faculty, of Pharmacy, Minia University, Minia, Egypt.
⁶ Department of Pharmaceutics, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
⁷ Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia. uahmedkauedu.sa@kau.edu.sa.
⁸ Department of Pharmaceutics and Industrial Pharmacy, Cairo University, Cairo, 11562, Egypt.
⁹ Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.
¹⁰ Mohamed Saeed Tamer Chair for Pharmaceutical Industries, King Abdulaziz University, 21589, Jeddah, Saudi Arabia.

No abstract available

Publication types